Verona Pharma plc (NASDAQ:VRNA – Get Free Report) CFO Mark W. Hahn sold 80,784 shares of the firm’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $4.39, for a total transaction of $354,641.76. Following the completion of the transaction, the chief financial officer now […]